Effects of IL-17 on expression of GRO-α and IL-8 in fibroblasts from nasal polyps

Abstract

Recent studies indicated that interleukin (IL)-17, growth-related oncogene (GRO)-α and IL-8 play an important role in the pathogenesis of nasal polyps. However, the effects of the increased amount of IL-17 and the production of GRO-α and IL-8 in human nasal polyp fibroblasts are not completely understood. This study aimed to determine the effects of the increased IL-17 on the changes of GRO-α and IL-8 expression in human nasal polyp fibroblasts and further investigate the mechanism of neutrophil infiltration in nasal polyps. Nasal polyp fibroblasts were isolated from six cases of human nasal polyps, and the cells were stimulated with five different concentrations of IL-17. Real-time fluorescence quantitative polymerase chain reaction (RT-PCR) was used to detect the mRNA expression of GRO-α and IL-8. The mRNA of GRO-α and IL-8 was expressed in unstimulated controls and remarkably increased by stimulation with IL-17. Moreover, the levels of GRO-α and IL-8 produced by fibroblasts were increased gradually with the increases in IL-17 concentrations. The present study showed that nasal fibroblasts can produce GRO-α and IL-8, and their production is remarkably enhanced by IL-17 stimulation, thereby clarifying the mechanism of the IL-17 mediated neutrophil infiltration in nasal polyps. These findings might provide a rationale for using IL-17 inhibitors as a treatment for nasal inflammatory diseases such as nasal polyps.

Keywords

nasal polyps / neutrophil infiltration / growth-related oncogene-α / interleukin-8 / interleukin-17

References

[1] FokkensW, LundV, BachertC, et al.. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy, 2005, 60(5): 583-601

[2] FokkensWJ, LundVJ, MullolJ, et al.. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology, 2012, 50(1): 1-12

[3] MeltzerEO, HamilosDL, HadleyJA, et al.. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol, 2004, 114(6Suppl): 155-212

[4] ZhangN, Van ZeleT, Perez-NovoC, et al.. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol, 2008, 122(5): 961-968

[5] CaoPP, LiHB, WangBF, et al.. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol, 2009, 124(3): 478-484

[6] LindénA, LaanM, AndersonGP. Neutrophils, interleukin-17A and lung disease. Eur Respir J, 2005, 25(1): 159-172

[7] JiangXD, LiGY, LiL, et al.. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy, 2011, 25(5): E171-E175

[8] ShenY, PanCK, TangXY, et al.. Significance of interleukin-17A in patients with nasal polyposis. Asian Pac J Allergy Immunol, 2011, 29(2): 169-175

[9] DeryckeL, ZhangN, HoltappelsG, et al.. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis. J Cystic Fibrosis, 2012, 11(3): 193-200

[10] SilvestriM, SabatiniF, ScarsoL, et al.. Fluticasone propionate downregulates nasal fibroblast functions involved in airway inflammation and remodeling. Int Arch Allergy Immunol, 2002, 128(1): 51-58

[11] NonakaM, OgiharaN, FukumotoA, et al.. Combined stimulation with Poly(I:C), TNF-alpha and Th2 cytokines induces TARC production by human fibroblasts from the nose, bronchioles and lungs. Int Arch Allergy Immunol, 2010, 152(4): 327-341

[12] RudackC, HermannW, EbleJ, et al.. Neutrophil chemokines in cultured nasal fibroblasts. Allergy, 2002, 57(12): 1159-1164

[13] RudackC, StollW, HermannW. Primary nasal epithelial cells and fibroblasts have inflammation-inducing functions. HNO, 2003, 51(6): 480-485

[14] Rostkowska-NadolskaB, Sliupkas-DyrdaE, PotykaJ, et al.. Vitamin D derivatives: calcitriol and tacalcitol inhibits interleukin-6 and interleukin-8 expression in human nasalpolyp fibroblast cultures. Adv Med Sci, 2010, 55(1): 86-92

[15] EustaceA, SmythLJ, MitchellL, et al.. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest, 2011, 139(5): 1089-1100

[16] HuXD, BaoYY, ZhouSH, et al.. Interleukin-17A expression in patients with chronic rhinosinusitis and its relationship with clinical features. J Int Med Res, 2013, 41(3): 777-784

[17] MoletSM, HamidQA, HamilosDL. IL-11 and IL-17 expression in nasal polyps: relationship to collagen deposition and suppression by intranasal fluticasone propionate. Laryngoscope, 2003, 113(10): 1803-1812

[18] RudackC, SachseF, AlbertyJ. Primary role of growth-related oncogene-alpha and granulocyte chemotactic protein-2 as neutrophil chemoattractants in chronic rhinosinusitis. Clin Exp Allergy, 2006, 36(6): 748-759

[19] LaanM, CuiZH, HoshinoH, et al.. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol, 1999, 162(4): 2347-2352

[20] WitowskiJ, PawlaczykK, BreborowiczA, et al.. IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J Immunol, 2000, 165(10): 5814-5821

[21] KleinAM, AndersonK, LafreniereD, et al.. Growth-related oncogene-alpha expression in human nasal polyps. Otolaryngol Head Neck Surg, 2000, 123(1Pt1): 85-90

[22] ScavuzzoMC, FattoriB, RuffoliR, et al.. Inflammatory mediators and eosinophilia in atopic and non-atopic patients with nasal polyposis. Biomed Pharmacother, 2005, 59(6): 323-329

[23] KostamoK, SorsaT, LeinoM, et al.. In vivo relationship between collagenase-2 and interleukin-8 but not tumour necrosis factor-alpha in chronic rhinosinusitis with nasal polyposis. Allergy, 2005, 60(10): 1275-1279

[24] PerićA, VojvodićD, PerićAV, et al.. Correlation between cytokine levels in nasal fluid and scored clinical parameters in patients with nasal polyposis. Indian J Otolaryngol Head Neck Surg, 2013, 65: S295-S300

[25] WuJ, BingL, JinH, et al.. Gene expression profiles of nasal polyps associated with allergic rhinitis. Am J Otolaryngol, 2009, 30(1): 24-32

[26] RudackC, MauneS, EbleJ, et al.. The primary role in biologic activity of the neutrophil chemokines IL-8 and GRO-alpha in cultured nasal epithelial cells. J Interferon Cytokine Res, 2003, 23(2): 113-123

[27] HommaH, KamiyaK, KusunokiT, et al.. Multiplex analyses of cytokine and chemokine release from the cultured fibroblast of nasal polyps: the effect of IL-17A. Acta Otolaryngol, 2013, 133(10): 1065-1072

[28] MoletS, HamidQ, DavoineF, et al.. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol, 2001, 108(3): 430-438

[29] JonesCE, ChanK. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-alpha, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am J Respir Cell Mol Biol, 2002, 26(6): 748-753

[30] PrauseO, LaanM, LötvallJ, et al.. Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells. Eur J Pharmacol, 2003, 462(1–3): 193-198

[31] LemmersA, MorenoC, GustotT, et al.. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology, 2009, 49(2): 646-657